Verapamil reduces coronary endothelium damage and cardiomyocyte necrosis but not apoptosis after ischemia and reperfusion: Ex vivo study in rat hearts

International Journal of Immunopathology and Pharmacology

Volumn 15, Issue 3, 2002, Pages 225-232

  Di Napoli, P ^a   Taccardi, A A ^a   Grilli, A ^a   Felaco, M ^a   Di Gioacchino, L ^a   De Caterina, R ^a   Barsotti, A ^a  

^a NONE   (Italy)

Author keywords

Apoptosis; Calcium blockers; Reperfusion injury; Verapamil

Indexed keywords

ALBUMIN; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE; DNA; FLUORESCEIN ISOTHIOCYANATE; VERAPAMIL;

AGAR GEL ELECTROPHORESIS; ANIMAL TISSUE; APOPTOSIS; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL DEATH; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART WEIGHT; ISOLATED HEART; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0036753852     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200201500309     Document Type: Article

References (35)

1. Park J.L. and B.R. Lucchesi. 1999. Mechanisms of myocardial reperfusion injury. Ann. Thorac. Surg. 68:1905.
2. Theroux P. 1999. Protection of the myocardial cell during ischemia. Am. J. Cardiol. 83:3G.
3. Jordan J.E., Z.Q. Zhao and J. Vinten-Johansen. 1999. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 43:860.
4. Zucchi R., S. Ronca-Testoni, P. Di Napoli, et al. 1996. Sarcoplasmic reticulum calcium uptake in human myocardium subjected to ischemia and reperfusion during cardiac surgery. J. Mol. Cell. Cardiol. 28:1693.
5. Saraste A., K. Pulkki, M. Kallajoki, et al. 1997. Apoptosis in human acute myocardial infarction. Circulation 95:320.
6. Fliss H. and D. Gattinger. 1996. Apoptosis in ischemic and reperfused rat myocardium. Circ. Res. 79:949.
7. Gottlieb R.A., K.O. Burleson, R.A. Kloner, et al. 1994. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94:1621.
8. Gao F., B. Gong, T.A. Christopher, et al. 2001. Antiapoptotic effect of benidipine, a long-lasting vasodilating calcium antagonist, in ischaemic/reperfused myocardial cells. Br. J. Pharmacol. 132:869.
9. Trump B.F. and I.K. Berezesky. 1995. Calcium-mediated cell injury and cell death. FASEB J. 9:919.
10. Bertolet B.D. 1999. Calcium antagonists in the post-myocardial infarction setting. Drugs Aging 15:461.
11. Sleight P. 1996. Calcium antagonists during and after myocardial infarction. Drugs 51:216.
12. Di Napoli P., A. Taccardi, A. Grilli, et al. 2001. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: An ex vivo study in isolated working rat hearts. Cardiovasc. Res. 51:283.
13. Di Napoli P., A. Di Crecchio, G. Contegiacomo, et al. 1998. Endothelial protective effect of verapamil against acute myocardial contractile dysfunction in isolated rat heart submitted to global ischemia. Ann. NY Acad. Sciences 853:311.
14. Weishaar R.E. and R.J. Bing. 1980. The beneficial effect of a calcium channel blocker, diltiazem, on the ischemic-reperfused heart. J. Mol. Cell. Cardiol. 12:993.
15. Sandmann S., R. Claas, J.P. Cleutjens, et al. 2001. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats. J. Cardiovasc. Pharmacol. 37:64.
16. Nayler W.G., R. Ferrari and A. Williams. 1980. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischaemic and reperfused myocardium. Am. J. Cardiol. 46:242.
17. Neglia D., G. Sambuceti, A. Giorgetti, et al. 2000. Effects of long-term treatment with verapamil on left ventricular function and myocardial blood flow in patients with dilated cardiomyopathy without overt heart failure. J. Cardiovasc. Pharmacol. 36:744.
18. Garcia-Villalon A.L., J. Padilla, N. Fernandez, et al. 1997. Role of endothelin receptors, calcium and nitric oxide in the potentiation by endothelin-1 of the sympathetic contraction of rabbit ear artery during cooling. Br. J. Pharmacol. 121:1659.
19. Khalfi F., B. Gressier, T. Dine, et al. 1998. Verapamil inhibits elastase release and superoxide anion production in human neutrophils. Biol. Pharm. Bull. 21:109.
20. Mak I.T. and W.B. Weglicki. 1990. Comparative antioxidant activities of propranolol, nifedipine, verapamil and diltiazem against sarcolemmal membrane lipid peroxidation. Circ. Res. 66:1449.
21. Guevara N.V. 2001. Apoptosis in atherosclerosis: Pathological and pharmacological implications. Pharmacol. Res. 44:59.
22. Martelli A.M., M. Zweyer, R.L. Ochs, et al. 2001. Nuclear apoptotic changes: An overview. J. Cell. Biochem. 82:634.
23. Ares M.P., M.I. Porn-Ares, J. Thyberg, et al. 1997. Ca2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells. J. Lipid Res. 38:2049.
24. Ray S.D., L.M. Kamendulis, M.W. Gurule, et al. 1993. Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J. 7:453.
25. Raafat A.M., M.T. Murray, T. McGuire, et al. 1997. Calcium blockade reduces renal apoptosis during ischemia reperfusion. Shock 8:186.
26. Toronyi E., J. Hamar, F. Perner, et al. 1999. Prevention of apoptosis reperfusion renal injury by calcium channel blockers. Exp. Toxicol. Pathol. 51:209.
27. Papadopoulos C. L., B.A. Kokkas and G. A. Anogiannakis. 2000. Beta blockers and atrial natriuretic peptide (ANP) in hypertension. Int. J. Immunopathol. Pharmacol. 13:107.
28. Castillo S., R. Revelen, A. Bordron, Y. Renaudineau, M. Dueymes and P. Youinou. 2001.Anti-endothelial cell reactivity, the unresolved enigma. Int. J. Immunopathol. Pharmacol. 14:109.
29. Stefano G.B., P.Cadet, C. Fimiani and H.I. Magazine. 2001. Morphine stimulates iNOS expression via a rebound from inhibition in human macrophages: Nitric Oxide involvement. Int. J. Immunopathol. Pharmacol. 14:129.
30. Conforti A., S. Lussignoli, S. Bertani, R. Ortolani, L. Cuzzolin, G. Benoni and P. Bellavite. 2001. Cytokine and nitric oxide levels in a rat model of immunologic protection from adjuvant-induced arthritis. Int. J. Immunopathol. Pharmacol. 14:153.
31. Hernandez M.R., J. Bozzo, R. Tonda, A.M. Galan, A. Ordinas and G. Escolar. 2001. Effect of anticoagulants on activation of polymorphonuclear leukocytes induced by shear stress. Int. J. Immunopathol. Pharmacol. 14:139.
32. Guagnano M.T., G. Davi and S. Sensi. 2000. Morning sudden cardiac death. Int. J. Immunopathol. Pharmacol. 13:55.
33. Di Gioacchino M., R. Forcucci, G.M. Tiboni, S. Kouri, F. Di Giacomo and P. Boscolo. 2000. The influence of menopause and habitual smoking upon serum zinc, serum copper, and the cardiovascular and immune parameters of women. Int. J. Immunopathol. Pharmacol. 13:91.
34. Antus B., M.S. Exton, and L. Rosivall. 2001. Angiotensin II: A regulator of inflammation during renal disease? Int. J. Immunopathol. Pharmacol. 14:25.
35. Jasuja R.R. and J.W. Mier. 2000. Differential effects of hydroxamate inhibitors on PMA- and ligand-induced L-section down-modulation: Role of membrane proximal and cytoplasmic domains. Int. J. Immunopathol. Pharmacol. 13:1.